Chemical Compound
4-Methyl-3-[4-(3-pyridyl)pyrimidin-2-ylamino]aniline; 4-Methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-benzenediamine; Imatinib Mesilate Imp. F (EP); N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine; 4-Methyl-N3-[4-(3-pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine; Imatinib Imp F (EP); 4-Methyl-N3-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine; Imatinib Mesilate Impurity F; Imatinib Impurity F
CAS Registry Number
152460-10-1
Primary record
4-Methyl-3-[4-(3-pyridyl)pyrimidin-2-ylamino]aniline; 4-Methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-benzenediamine; Imatinib Mesilate Imp. F (EP); N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine; 4-Methyl-N3-[4-(3-pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine; Imatinib Imp F (EP); 4-Methyl-N3-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine; Imatinib Mesilate Impurity F; Imatinib Impurity F
- 库存
- 3,106 克
- 纯度
- 99.0 %
- CAS
- 152460-10-1
化合物标识与属性
- CAS
- 152460-10-1
- PubChem CID
- 9965429
- SMILES
- CC1=C(C=C(C=C1)N)NC2=NC=CC(=N2)C3=CN=CC=C3
- Canonical SMILES
- Cc1ccc(N)cc1Nc1nccc(-c2cccnc2)n1
名称与同义词
- 152460-10-1
- N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine
- Imatinib amine
- Imatinib EP Impurity F
- JR9RZF7KDS
- Imatinib Impurity F
- Imatinib amine [USP]
- NORBOLETHONE
- zlchem 1354
- Imatinib amine (USP)
- UNII-JR9RZF7KDS
- Imatinib impurity F CRS
- MFCD09028125
- RefChem:790600
- ACMC-209d7r
- PKC-IN-6
- SCHEMBL2392
- CHEMBL278103
- C16H15N5
- KSC174K2P
- 2-(5-Amino-2-methylanilino)-4-(3-pyridyl)pyrimidine
- QGAIPGVQJVGBIA-UHFFFAOYSA-N
- BEN021
- Imatinib related compound F [USP]
- Jsp002938
- 6-methyl-N1-(4-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,3-diamine
- SCHEMBL29366999
- SCHEMBL29555505
- CTK0H4527
- DTXSID30433443
- ZLE0132
- IMATINIB AMINE [USP IMPURITY]
- Ethyl triphenyl phosphonium bromide
- Imatinib related compound F (USP)
- ACT04895
- BCP22918
- AC-619
- ANW-21397
- BDBM50287097
- CA0157
- NP3278
- VCC489937
- ZINC21985310
- IMATINIB AMINE (USP IMPURITY)
- AKOS015888614
- AC-2147
- ACN-026829
- AN-7039
- CCG-310976
- CID9965429
- CS-T-03090
- CS-W014568
- DS-0284
- EBC-170061
- FA15934
- LS41060
- QC-1118
- RP29768
- RTX-011154
- SB60556
- TRA-0195164
- 112GI007
- 4-methyl-3-[4-(3-pyridyl)pyrimidin-2-ylamino]aniline
- AJ-79342
- AK-23922
- AT-20154
- BR-23922
- CJ-17093
- N-(5-Amino-o-tolyl)-4-(3-pyridyl)-2-pyrimidinamine
- R756
- SC-19340
- SY046834
- 4-Methyl-N3-[4-(3-Pyridinyl)-2-Pyrimidinyl]-1,3-Benzenediamine
- AB0005260
- AB1004617
- J764.280F
- 4CH-006386
- A2308
- A3351
- AM20050827
- FT-0647597
- FT-0655675
- FT-0696298
- Imatinib Mesilate Imprity F [EP IMPURITY]
- NS00077786
- ST24033278
- IMATINIB RELATED COMPOUND F [USP IMPURITY]
- N-(5-Amino-2-methylphenyl)-4-(3-pyridinyl)-2-pyrimidineamine
- VU0549314-1
- 4-methyl-3-N-(4-pyridin-3-ylpyrimidin-2-yl)benzene-1,3-diamine
- EC 442-110-5
- M-1404
- 1,3-Benzenediamine, 4-methyl-N3-(4-(3-pyridinyl)-2-pyrimidinyl)-
- 1,3-Benzenediamine, 4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-
- EN300-7372570
- N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinamine
- 460A101
- 6-METHYL-N1-[4-(PYRIDIN-3-YL)PYRIMIDIN-2-YL]BENZENE-1,3-DIAMINE
- F080006
- IMATINIB RELATED COMPOUND F (USP IMPURITY)
- 4-Methyl-N3-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine
- I01-1233
- I14-2828
- N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimid
- N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine
- 4-methyl-N3-[4-(3-pyridyl)pyrimidin-2-yl]benzene-1,3-diamine
- F9995-0188
- N-(5-Amino-o-to lyl)-4-(3-pyridyl)-2-pyrimidinamine
- Z1741977607
- 4-Methyl-N*3*-(4-pyridin-3-yl-pyrimidin-2-yl)-benzene-1,3-diamine
- 4-Methyl-N3-(4-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,3-diamine
- 4-Methyl-N3-(4-phenylpyrimidine-2-yl)benzene-1,3-diamine
- (2-Methyl-5-aminophenyl)(4-(3-pyridyl)pyrimidine-2-yl)amine
- 3-[[4-(3-Pyridinyl)pyrimidine-2-yl]amino]-4-methylaniline
- 4-(3-Pyridinyl)-N-(3-amino-6-methylphenyl)pyrimidin-2-amine
- N-(2-methyl-5-amino phenyl)-4-(3-pyridyl) -2-pyrimidinamine
- N-(2-Methyl-5-aminophenyl)-4-(3-pyridinyl)pyrimidine-2-amine
- n-(2-methyl-5-aminophenyl)-4-(3-pyridyl)-2-pyrimidine amine
- N-(2-Methyl-5-aminophenyl)-4-(3-pyridyl)pyrimidine-2-amine
- N-(5-Amino-2-methyl phenyl)-4-(3-pyridyl)-2-pyrimidineamine
- N-(5-Amino-2-methylphenyl)-4-(3-pridyl)-2-pyrimidineamine
- N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2- pyrimidineamine
- N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine amine
- N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)pyrimidine-2-amine
- 1,3-Benzenediamine, 4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl
- 4-methyl-n'-(4-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,3-diamine
- 4-methyl-N'-(4-pyridin-3-ylpyrimidin-2-yl)benzene-1,3-diamine
- 4-Methyl-N'-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine
- 4-Methyl-N-3-(4-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,3-diamine
- 4-methyl-N~3~-(4-pyridin-3-ylpyrimidin-2-yl)benzene-1,3-diamine
- 4-methyl-N3-[4-(3-piridinyl)-2-pirimidinyl]-1,3-benzendiamine
- 4-Methyl-N3-[4-(3-pyridyl)-2-pyrimidinyl]-1,3-phenylenediamine
- 6-methyl-1-N-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine
- 6-Methyl-N-(4-(pyridine-3-yl)pyrimidin-2-yl)benzene-1,3-diamine
- 6-Methyl-N1-(4-(pyridine-3-yl)pyrimidin-2-yl)benzene-1,2-diamine
- 6-Methyl-N1-[4-(3-pyridyl)-2-pyrimidinyl]-1,3-benzenediamine
- N -[4-(3-Pyridyl)-2-pyrimidinyl]-4-methyl-1,3-phenylenediamine
- N-(5-amino-2-methyl phenyl)-4-(3-pyridinyl)2-pyrimidine-amine
- N-(5-amino-2-methylphenyl)-4-(3-pyridinyl)-2-pyrimidine-amine
- 4-Methyl-N -[4-(pyridine-3-yl)pyrimidine-2-yl]benzene-1,3-diamine
- 4-Methyl-N~3~-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine
- 782450-12-8
- Heta1563 2-Dicyclohexylphosphino-2',4',6'-tri-i-propyl-1,1'-biphenyl,X-PHOS
- N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine, 99% - 1G 1g
- 1235-15-0
- 4-Methyl-3-[4-(3-pyridyl)pyrimidin-2-ylamino]aniline; 4-Methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-benzenediamine; Imatinib Mesilate Imp. F (EP); N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine; 4-Methyl-N3-[4-(3-pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine; Imatinib Imp F (EP); 4-Methyl-N3-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine; Imatinib Mesilate Impurity F; Imatinib Impurity F
- 4-Methyl-N3-[4-(3-pyridyl)-2-pyrimidinyl]-1,3-phenylenediamine; N-(5-Amino-o-tolyl)-4-(3-pyridyl)-2-pyrimidinamine
- 442-110-5
- 604-859-8